We also measured IL-2 expression following 5 h PMA stimulation and found that CD26high followed by CD26low T cells had a superior capacity for IL-2 production compared to CD26neg CD8+ T cells in CLL patients (Fig. 4I, J). This evidence concerns the gene IL2 and B-cell chronic lymphocytic leukemia.